These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11321240)

  • 1. Changes in the pathogenesis and prevention of chronic lung disease of prematurity.
    Bancalari E
    Am J Perinatol; 2001; 18(1):1-9. PubMed ID: 11321240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.
    Rojas MA; Gonzalez A; Bancalari E; Claure N; Poole C; Silva-Neto G
    J Pediatr; 1995 Apr; 126(4):605-10. PubMed ID: 7699543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of bronchopulmonary dysplasia.
    Hayes D; Feola DJ; Murphy BS; Shook LA; Ballard HO
    Respiration; 2010; 79(5):425-36. PubMed ID: 19786727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acinar arterial changes with chronic lung disease of prematurity in the surfactant era.
    Thibeault DW; Truog WE; Ekekezie II
    Pediatr Pulmonol; 2003 Dec; 36(6):482-9. PubMed ID: 14618639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current perspectives on the prevention and management of chronic lung disease in preterm infants.
    Shah PS
    Paediatr Drugs; 2003; 5(7):463-80. PubMed ID: 12837119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent ductus arteriosus and respiratory outcome in premature infants.
    Bancalari E; Claure N; Gonzalez A
    Biol Neonate; 2005; 88(3):192-201. PubMed ID: 16210841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "New" bronchopulmonary dysplasia and chronic lung disease.
    Voynow JA
    Paediatr Respir Rev; 2017 Sep; 24():17-18. PubMed ID: 28697967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bronchopulmonary dysplasia in the newborn infant. Occurrence of bronchopulmonary dysplasia in the severe neonatal respiratory syndrome complicated by patent ductus arteriosus treated with mechanical ventilation, in newborn infants of gestational age under 36 weeks].
    Silvestri G; Tuo P; Soliani M; Moretti R; Nahum L; Ivani G
    Minerva Pediatr; 1984 Feb; 36(4):163-8. PubMed ID: 6738469
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic lung disease of the very low birth weight infant--is it preventable?
    Ogawa Y
    Turk J Pediatr; 1998; 40(1):35-44. PubMed ID: 9673527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association.
    Marshall DD; Kotelchuck M; Young TE; Bose CL; Kruyer L; O'Shea TM
    Pediatrics; 1999 Dec; 104(6):1345-50. PubMed ID: 10585987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.
    Ng GY; da S; Ohlsson A
    Cochrane Database Syst Rev; 2001; (3):CD003214. PubMed ID: 11687053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of bronchopulmonary dysplasia.
    Chess PR; D'Angio CT; Pryhuber GS; Maniscalco WM
    Semin Perinatol; 2006 Aug; 30(4):171-8. PubMed ID: 16860156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and prevention of chronic lung disease in the neonate.
    Askin DF; Diehl-Jones W
    Crit Care Nurs Clin North Am; 2009 Mar; 21(1):11-25, v. PubMed ID: 19237040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Quality Improvement Tools to Reduce Chronic Lung Disease.
    Picarillo AP; Carlo W
    Clin Perinatol; 2017 Sep; 44(3):701-712. PubMed ID: 28802347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From classic to new bronchopulmonary dysplasia].
    Kramer BW; Lievense S; Been JV; Zimmermann LJ
    Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia.
    Willis KA; Weems MF
    Congenit Heart Dis; 2019 Jan; 14(1):27-32. PubMed ID: 30343505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less.
    Gonzalez A; Sosenko IR; Chandar J; Hummler H; Claure N; Bancalari E
    J Pediatr; 1996 Apr; 128(4):470-8. PubMed ID: 8618179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2000; (2):CD001146. PubMed ID: 10796252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.